MedPath

BlaaskankerZorg In Beeld

Recruiting
Conditions
Bladder cancer
Registration Number
NL-OMON26633
Lead Sponsor
Dutch Cancer Society (KWF Kankerbestrijding)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
6500
Inclusion Criteria

All newly diagnosed Dutch patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIB; Cis and T1) and Muscle invasive Bladder Cancer (MIBC; =T2) between November 1st 2017 and end 2019 in the Netherlands.

Exclusion Criteria

NA

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oncological outcomes (disease recurrence, progression, mortality, disease-free survival and overall survival) and Health-related quality of life
Secondary Outcome Measures
NameTimeMethod
Complications, toxicity, complete pathological response, downstaging
© Copyright 2025. All Rights Reserved by MedPath